No results for ‘’
₹-
(-%)
Tue, 25 Aug 2026, 03:30 pm
Share Price Live Chart
1 Day
(-%)
No Result Found
Summary
Market Cap (in Cr)
34880.58
Net Profit (in Cr)
659.58
P/B
7.36
Sector P/E
33.76
P/E
38.29
EV/EBITDA
23.50
Debt/Equity (Industry)
0.24
Interest Cover (Industry)
9.79
ROCE (Industry)
14.04
RONW (Industry)
13.17
ROE
20.75
ROCE
26.42
Debt/Equity
0.06
EPS (TTM)
45.45
Dividend Yield
1.01
Book Value
259.05
Interest Cover
76.65
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 48.80 | 47.55 | 47.56 | 47.73 | 47.84 |
| FII | 16.33 | 14.88 | 15.30 | 17.77 | 18.31 |
| DII | 21.38 | 23.36 | 22.83 | 19.63 | 18.72 |
| Public | 13.48 | 14.22 | 14.30 | 14.88 | 15.13 |
| Government | 0.00 | 0.00 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - | - | - | - | - | - | - |
| Fibonacci | - | - | - | - | - | - | - |
| Camarilla | - | - | - | - | - | - | - |
Pivots Level: Classic
R3
+-
-
R2
+-
-
R1
+-
-
S1
--
-
S2
--
-
S3
--
-
Moving Average
Period
Value
10-EMA
-
20-EMA
-
30-EMA
-
50-EMA
-
100-EMA
-
200-EMA
-
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 25 May 2026 | agm | ||
| 11 May 2026 | dividend | ₹9.30 Dividend /Share | 29 May 2026 |
| 11 May 2026 | board-meetings | Accounts, Final Dividend | |
| 27 Mar 2026 | egm | ||
| 05 Feb 2026 | dividend | ₹12.70 Dividend /Share | 11 Feb 2026 |
| 16 Jan 2026 | board-meetings | Quarterly Results | |
| 11 Jan 2026 | dividend | Interim Dividend - Rs. - 12.7 | 11 Feb 2026 |
| 11 Nov 2025 | board-meetings | Quarterly Results, Half Yearly Results | |
| 11 Jul 2025 | agm | ||
| 30 Jun 2025 | dividend | Final Dividend - Rs. - 7 | 30 Jul 2025 |
Peer Comparison
J B Chemicals & Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd
Divis Laboratories Ltd
Cipla Ltd
Dr Reddys Laboratories Ltd
Sun Pharmaceutical Industries Ltd
About
J B Chemicals & Pharmaceuticals is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and Active Pharmaceutical Ingredients (APIs).
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1976
Headquarters
CEO
Arun Duggal
Employees
Contact
Website
http://www.jbpharma.com
investorelations@jbpharma.com; secretarial@jbpharm
Phone
91-022-2482 2222/2493 0918
Location
Neelam Centre 4th Floor, B-Wing Hind Cycle Road Worli, Mumbai, Maharashtra, 400030
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| TAU INVESTMENT HOLDINGS PTE LIMITED | bulk | Sell | 2245786 | 1625.01 | 27 Mar 2025 |
| KOTAK MAHINDRA MUTUAL FUND | bulk | Buy | 1230769 | 1625 | 27 Mar 2025 |
| TAU INVESTMENT HOLDINGS PTE LIMITED | bulk | Sell | 2245786 | 1625 | 27 Mar 2025 |
| TAU INVESTMENT HOLDINGS PTE LIMITED | bulk | Sell | 2245787 | 1625 | 27 Mar 2025 |
| TAU INVESTMENT HOLDINGS PTE LIMITED | bulk | Sell | 2245786 | 1625.34 | 27 Mar 2025 |
| BNP PARIBAS ARBITRAGE | block | Sell | 104241 | 1693.8 | 25 Jan 2024 |
| SOCIETE GENERALE | block | Buy | 104241 | 1693.8 | 25 Jan 2024 |
| THE VANGUARD GROUP INC A/C VANGUARD EMERG. MKTS STOCK INDEXFD A SERIES OF V I E I F | bulk | Buy | 706756 | 1121.89 | 18 Sept 2020 |
| ASHISH DHAWAN | bulk | Sell | 472096 | 289.54 | 02 Nov 2017 |
| ICICI LOMBARD GENERAL INSURANCE CO LIMITED | bulk | Buy | 2000000 | 288 | 01 Nov 2017 |